Five-year risk of HIV diagnosis subsequent to 147 hospital-based indicator diseases: a Danish nationwide population-based cohort study [Erratum]

Figures & data

Table 2 Ten combinations of indicator disease, sex and age in the Danish population and the African population with the highest FYRHD

Indicator disease	Population	FYRHD (95% CI)
Lymphoma	African	22.105 (6.397–43.665)
Thrombocytopenia	African	18.000 (8.799–29.824)
Herpes zoster	African	17.891 (10.302–27.171)
Pneumococcal pneumonia	African	15.000 (3.560–33.991)
Syphilis	African	11.364 (4.105–22.735)
Viral meningitis and encephalitis	African	10.256 (3.199–22.169)
Other CNS infections	African	8.511 (2.679–18.691)
Mononucleosis	African	6.250 (0.362–25.479)
Candida infection	African	5.000 (1.610–11.379)
Lung abscess/empyema without pneumonia	African	4.762 (0.304–20.204)
Syphilis	Male 30 years	13.376 (7.465–21.024)
Hepatitis A	Male 20 years	7.805 (3.417–14.566)
Syphilis	Male 50 years	7.038 (2.838–13.844)
Syphilis	Male 40 years	6.101 (1.943–13.740)
Hepatitis A	Male 30 years	5.464 (2.403–10.369)
Endocarditis	Female 20 years	4.774 (1.763–10.111)
Candida infection	Male 30 years	4.009 (2.463–6.121)
Syphilis	Male 20 years	4.000 (1.298–9.209)
Other STIs	Male 30 years	3.997 (2.370–6.266)
Non ‘A’ viral hepatitis	Male 30 years	3.551 (2.811–4.417)

Abbreviations: FYRHD, 5-year risk of an HIV diagnosis; CI, confidence interval; CNS, central nervous system; STIs, sexually transmitted infections.